Annual Information Update (3831B)
April 16 2012 - 4:57AM
UK Regulatory
TIDMHIK
RNS Number : 3831B
Hikma Pharmaceuticals Plc
16 April 2012
Annual Information Update
London, 16 April 2012. In accordance with Prospectus Rule 5.2,
Hikma Pharmaceuticals PLC ("Hikma" or "the Company") (LSE: HIK)
sets out below a summary of the information which has been
published or made available to the public over the period. The
information referred to in this Update was up to date at the time
the information was published, but some information may now be out
of date.
Stock Exchange Announcements
Announcements made by the Company via RNS, a Regulatory
Information Service, may be viewed and downloaded from the
Company's market news section on the London Stock Exchange website
at
(http://www.londonstockexchange.com/prices-and-news/stocks/stocks-and-prices.htm)
or from the press releases page on the Company's website at
(http://www.hikma.com/investorrelations/rns/). The Stock Exchange
announcements made during the period were:
Date of Announcement Headline of Announcement
--------------------- ---------------------------------------------
13/04/2012 Annual Financial Report & AGM Notice
--------------------- ---------------------------------------------
04/04/2012 Company Secretary Change
--------------------- ---------------------------------------------
02/04/2012 Total Voting Rights
--------------------- ---------------------------------------------
02/04/2012 Blocklisting Interim Review
--------------------- ---------------------------------------------
28/03/2012 Director/PDMR Shareholding
--------------------- ---------------------------------------------
19/03/2012 Director/PDMR Shareholding
--------------------- ---------------------------------------------
16/03/2012 Director/PDMR Shareholding
--------------------- ---------------------------------------------
14/03/2012 Preliminary Results
--------------------- ---------------------------------------------
12/03/2012 Holding(s) in Company
--------------------- ---------------------------------------------
14/02/2012 Total Voting Rights
--------------------- ---------------------------------------------
02/02/2012 Holding(s) in Company
--------------------- ---------------------------------------------
01/02/2012 Director Declaration
--------------------- ---------------------------------------------
17/01/2012 Tender Offer
--------------------- ---------------------------------------------
13/01/2012 Director/PDMR Shareholding
--------------------- ---------------------------------------------
12/01/2012 Total Voting Rights
--------------------- ---------------------------------------------
22/12/2011 Additional Listing
--------------------- ---------------------------------------------
02/12/2011 Tender Offer
--------------------- ---------------------------------------------
01/12/2011 Holding(s) in Company
--------------------- ---------------------------------------------
11/11/2011 Total Voting Rights
--------------------- ---------------------------------------------
04/11/2011 Interim Management Statement
--------------------- ---------------------------------------------
24/10/2011 Director/PDMR Shareholding
--------------------- ---------------------------------------------
18/10/2011 Director/PDMR Shareholding
--------------------- ---------------------------------------------
18/10/2011 Director/PDMR Shareholding
--------------------- ---------------------------------------------
18/10/2011 Director/PDMR Shareholding
--------------------- ---------------------------------------------
17/10/2011 Tender Offer
--------------------- ---------------------------------------------
07/10/2011 Blocklisting Interim Review
--------------------- ---------------------------------------------
06/10/2011 Dividend Declaration
--------------------- ---------------------------------------------
03/10/2011 Acquisition
--------------------- ---------------------------------------------
25/08/2011 Directorate Change
--------------------- ---------------------------------------------
25/08/2011 Interim Results
--------------------- ---------------------------------------------
19/08/2011 Trading Statement
--------------------- ---------------------------------------------
26/07/2011 Total Voting Rights
--------------------- ---------------------------------------------
11/07/2011 Hikma enhances its API sourcing capabilities
--------------------- ---------------------------------------------
01/06/2011 Total Voting Rights
--------------------- ---------------------------------------------
26/05/2011 Director/PDMR Shareholding
--------------------- ---------------------------------------------
25/05/2011 Holding(s) in Company
--------------------- ---------------------------------------------
17/05/2011 Director/PDMR Shareholding
--------------------- ---------------------------------------------
13/05/2011 Director/PDMR Shareholding
--------------------- ---------------------------------------------
13/05/2011 Dividend Declaration
--------------------- ---------------------------------------------
12/05/2011 AGM Statement
--------------------- ---------------------------------------------
12/05/2011 Interim Management Statement
--------------------- ---------------------------------------------
09/05/2011 Director/PDMR Shareholding
--------------------- ---------------------------------------------
09/05/2011 Total Voting Rights
--------------------- ---------------------------------------------
09/05/2011 Annual Information Update
--------------------- ---------------------------------------------
03/05/2011 Statement re Completion of Acquisition
--------------------- ---------------------------------------------
All of the above announcements were also made by the Company via
the Nasdaq Dubai stock exchange CANDI system. These announcements
may be viewed and downloaded from the Nasdaq Dubai website
(www.candi.nasdaq.com).
Documents filed with the Financial Services Authority
The Company has filed the following documents with the Financial
Services Authority ("FSA") visa the National Storage Mechanism over
the previous 12 months. These documents are available at
http://www.hemscott.com/nsm.do or at the Company's registered
office.
Date Document
-------------- ----------------------------------------
13 April 2012 Annual Report and Accounts 2011
-------------- ----------------------------------------
13 April 2012 Notice of 2012 Annual General Meeting
-------------- ----------------------------------------
13 April 2012 Proxy forms for the 2012 Annual General
Meeting
-------------- ----------------------------------------
Documents filed with Companies House
The Company submitted filings to the Registrar of Companies in
England and Wales as detailed in the table below.
Date Filed Form Description
----------- ------ ---------------------------------------------
11/04/2012 AP03 Secretary Appointed, Peter Alexander
Speirs
----------- ------ ---------------------------------------------
11/04/2012 TM02 Secretary Appointment Terminated, Henry
Knowles
----------- ------ ---------------------------------------------
22/03/2012 SH01 31/01/12 Statement of Capital GBP 19,586,621
----------- ------ ---------------------------------------------
22/03/2012 SH01 22/03/12 Statement of Capital GBP 19,586,621
----------- ------ ---------------------------------------------
12/01/2012 SH01 31/12/11 Statement of Capital GBP 19,582,971
----------- ------ ---------------------------------------------
28/11/2011 SH01 31/10/11 Statement of Capital GBP 19,535,931
----------- ------ ---------------------------------------------
21/10/2011 MG01 Particulars of a Mortgage or Charge
/ Charge No: 1
----------- ------ ---------------------------------------------
19/09/2011 RES01 Adopt Articles 13/05/2010
----------- ------ ---------------------------------------------
19/09/2011 CC04 Statement of Company's Objects
----------- ------ ---------------------------------------------
12/09/2011 AR01 08/09/11 Full List
----------- ------ ---------------------------------------------
02/09/2011 AP01 Director Appointed Robert Mark Pickering
----------- ------ ---------------------------------------------
18/08/2011 SH01 30/06/11 Statement of Capital GBP 19,533,781
----------- ------ ---------------------------------------------
29/06/2011 SH01 31/05/11 Statement of Capital GBP 19,491,421
----------- ------ ---------------------------------------------
20/05/2011 RES13 Approval of Waiver 12/05/2011
----------- ------ ---------------------------------------------
19/05/2011 AA Group of Companies' Accounts Made up
to 31/12/10
----------- ------ ---------------------------------------------
10/05/2011 SH01 30/04/11 Statement of Capital GBP 19,485,361
----------- ------ ---------------------------------------------
Copies of all these documents may be obtained from Companies
House, Crown Way, Maindy, Cardiff CF14 3UZ or, if you are a
registered user, they may be viewed and downloaded using Companies
House Direct at www.direct.companieshouse.gov.uk.
Further Information
Further information about Hikma Pharmaceuticals PLC can be found
at our website www.hikma.com. Copies of all documents can be
obtained from the Company at the registered office which is located
at 13 Hanover Square, London W1S 1HW.
Peter Speirs
Company Secretary 16 April 2012
- ENDS -
Enquiries:
Hikma Pharmaceuticals PLC
Peter Speirs
Company Secretary +44 20 7399 2670
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational
pharmaceutical group focused on developing, manufacturing and
marketing a broad range of both branded and non--branded generic
and in--licensed products. Hikma's operations are conducted through
three businesses: "Branded", "Injectables" and "Generics" based
principally in the Middle East and North Africa ("MENA") region,
where it is a market leader, the United States and Europe. In 2011,
Hikma achieved revenue of $918.0 million and profit attributable to
shareholders of $80.1 million.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AIUVQLBFLZFEBBQ
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
